TEVA Teva Pharmaceutical Industries Limited Stock Quote

TEVA [NYSE]

Index	-	P/E	-	EPS (ttm)	-3.64	Insider Own	1.02%	Shs Outstand	1.10B	Perf Week	-3.82%
Market Cap	12.13B	Forward P/E	3.82	EPS next Y	2.77	Insider Trans	-4.47%	Shs Float	1.09B	Perf Month	-13.49%
Income	-3990.00M	PEG	-	EPS next Q	0.60	Inst Own	52.80%	Short Float	3.17%	Perf Quarter	12.43%
Sales	16.66B	P/S	0.73	EPS this Y	-297.90%	Inst Trans	1.98%	Short Ratio	3.56	Perf Half Y	11.49%
Book/sh	9.16	P/B	1.16	EPS next Y	5.60%	ROA	-7.60%	Target Price	12.35	Perf Year	-6.95%
Cash/sh	1.90	P/C	5.57	EPS next 5Y	5.60%	ROE	-34.00%	52W Range	6.25 - 13.30	Perf YTD	9.64%
Dividend	-	P/FCF	19.02	EPS past 5Y	-32.00%	ROI	-9.50%	52W High	-20.45%	Beta	1.44
Dividend %	-	Quick Ratio	0.70	Sales past 5Y	-3.30%	Gross Margin	46.80%	52W Low	69.28%	ATR	0.47
Employees	39717	Current Ratio	1.00	Sales Q/Q	11.60%	Oper. Margin	-21.40%	RSI (14)	40.98	Volatility	3.46% 4.33%
Optionable	Yes	Debt/Eq	2.59	EPS Q/Q	37.10%	Profit Margin	-24.00%	Rel Volume	1.43	Prev Close	10.92
Shortable	Yes	LT Debt/Eq	2.27	Earnings	Feb 10 BMO	Payout	-	Avg Volume	9.68M	Price	10.58
Recom	2.80	SMA20	-7.43%	SMA50	-6.01%	SMA200	-1.55%	Volume	13,820,807	Change	-3.11%

Nov-25-20

Initiated

Oppenheimer

Perform

Aug-06-20

Upgrade

Barclays

Underweight → Equal Weight

$10 → $13

Jul-27-20

Resumed

Goldman

Neutral

$12

Jun-01-20

Upgrade

SunTrust

Hold → Buy

Apr-24-20

Resumed

Citigroup

Neutral

$10

Apr-06-20

Upgrade

UBS

Neutral → Buy

$14 → $12

Feb-24-20

Downgrade

Edward Jones

Hold → Sell

Nov-12-19

Upgrade

JP Morgan

Underweight → Neutral

Oct-17-19

Upgrade

Gabelli & Co

Hold → Buy

Aug-07-19

Downgrade

Evercore ISI

Outperform → In-line

Jul-19-19

Initiated

Wolfe Research

Peer Perform

Jul-15-19

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Jul-10-19

Resumed

Credit Suisse

Neutral

Jul-05-19

Upgrade

Argus

Hold → Buy

Jun-11-19

Initiated

Barclays

Underweight

Jun-03-19

Upgrade

Oppenheimer

Perform → Outperform

$12

May-30-19

Downgrade

BofA/Merrill

Buy → Underperform

May-28-19

Downgrade

UBS

Buy → Neutral

Mar-20-19

Initiated

SunTrust

Hold

Mar-07-19

Resumed

UBS

Buy

$22

Mar-03-21 05:51AM	3 Value Stocks That'll Make You Richer in March (and Beyond) Motley Fool
Mar-01-21 04:00PM	Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference Business Wire
Feb-28-21 07:00AM	A Giant Pension Bought Up PG&E, Zoom, and a Stock Elon Musk Loves Barrons.com
Feb-26-21 08:00AM	New Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments Business Wire
Feb-21-21 06:20AM	Is Teva Pharmaceuticals a Safe Stock to Buy Now? Motley Fool
Feb-20-21 06:30AM	2 Stocks I'd Avoid at All Costs Motley Fool
Feb-18-21 11:08AM	Bill Gates: with vaccine acceptance U.S. will be back to normal by fall Yahoo Finance Video
07:15AM	J&J Seeks FDA Authorization For Covid Vaccine; Is JNJ Stock A Buy Now? Investor's Business Daily
Feb-12-21 12:40AM	The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts Simply Wall St.
Feb-11-21 10:25AM	TEVA Stock Declines Despite Q4 Earnings and Sales Beat Zacks -5.20%
09:14AM	Teva CEO Sees Risks in Relying on China for Drug Ingredients Barrons.com
Feb-10-21 06:00PM	Teva Pharmaceutical Industries (TEVA) Q4 2020 Earnings Call Transcript Motley Fool -6.95%
01:50PM	Coronavirus update: CDC endorses double-masking as COVID vaccine push continues Yahoo Finance
10:19AM	Exclusive: Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says Reuters
09:31AM	Teva Stock Climbs as Earnings Hint at Turnaround Barrons.com
09:26AM	TEVA Q4 Earnings & Sales Beat Estimates, Stock Rises Zacks
07:52AM	UPDATE 2-Teva Pharm sees growth in two main branded drugs in otherwise flat 2021 Reuters
07:48AM	Teva's stock rallies 2% on earnings MarketWatch
07:16AM	Recap: Teva Pharmaceutical Q4 Earnings Benzinga
07:00AM	Teva Reports Fourth Quarter and Full Year 2020 Financial Results Business Wire
06:15AM	Teva Pharmaceutical Industries Ltd. to Host Earnings Call ACCESSWIRE
03:41AM	Teva's Fourth-Quarter Adjusted Earnings Top Forecasts TheStreet.com
Feb-09-21 11:50AM	Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock? Zacks
Feb-08-21 11:00PM	Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript Motley Fool
10:33AM	TEVA Gears Up to Report Q4 Earnings: What's in the Cards? Zacks
Feb-07-21 06:36AM	Forget Bitcoin: These Controversial Stocks Are Better Buys Motley Fool
Jan-31-21 05:51AM	5 Deeply Discounted Stocks to Buy for a Biden Bull Market Motley Fool
Jan-26-21 05:48AM	Is Teva Pharmaceutical Industries Limited (NYSE:TEVA) Popular Amongst Institutions? Simply Wall St.
Jan-14-21 05:17PM	Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States Business Wire
Jan-09-21 05:51AM	5 Value Stocks That Will Make You Richer in 2021 Motley Fool
Jan-08-21 03:01PM	Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 Business Wire
Jan-07-21 04:00PM	Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
08:00AM	Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia Business Wire
Jan-06-21 06:06AM	5 Buffett Stocks to Buy Hand Over Fist in 2021 Motley Fool
Jan-04-21 05:51AM	8 Stocks That Could Double Your Money in 2021 Motley Fool +7.15%
Jan-02-21 05:45PM	Billionaire David Abrams Top 10 Stock Picks Insider Monkey
Dec-29-20 06:06AM	My Top 5 Portfolio Holdings for 2021 Motley Fool
Dec-21-20 05:27PM	Is TEVA A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-18-20 10:25AM	IWH UK Midco Limited -- Moody's downgrades IWH UK Finco Limited's ('Theramex') ratings to B3; changes outlook to stable from negative Moody's
Dec-17-20 06:06AM	3 of the Biggest Bargains in Buffett's Portfolio Motley Fool
Dec-16-20 01:57PM	21 Largest Generic Drug Companies Insider Monkey
Dec-15-20 10:55AM	Teva Pharmaceutical Finance Netherlands II BV -- Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd Moody's
Nov-27-20 09:40AM	Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now? Zacks
02:22AM	Teva Pharmaceutical Industries Limited (NYSE:TEVA): Are Analysts Optimistic? Simply Wall St.
Nov-26-20 06:43AM	EU fines Teva, Cephalon 60.5 mln euros for delaying cheaper drug Reuters
Nov-23-20 08:52AM	DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses of $100,000 to Contact the Firm Business Wire
Nov-20-20 03:00PM	5 Warren Buffett Stocks To Buy For Under $25 Benzinga
11:17AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Nov-19-20 09:41PM	TEVA SHAREHOLDER NOTICE Newsfile
09:52AM	MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Nov-18-20 09:40PM	Teva Shareholder Alert Newsfile
09:44AM	MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Nov-17-20 08:48PM	Teva Deadline Alert Newsfile
Nov-15-20 10:55AM	Teva Lead Plaintiff Deadline Alert Newsfile
Nov-14-20 03:20PM	ROSEN, A LEADING AND RESPECTED LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA PR Newswire
10:51AM	Teva Update Newsfile
Nov-13-20 01:25PM	TEVA ALERT: A GLOBAL AND LONGSTANDING ROSEN LAW FIRM, Encourages Teva Pharmaceuticals Industries Limited Investors To Contact Firm Before Important November 23 Deadline in Securities Class Action - TEVA ACCESSWIRE
10:29AM	Understanding Teva Pharmaceutical Indus's Unusual Options Activity Benzinga
Nov-12-20 09:01PM	Teva Class Action Reminder Newsfile
07:21AM	4 Must-Own Turnaround Stocks With Biden as President Motley Fool
Nov-11-20 08:55PM	Teva Shareholder Notice Newsfile
03:55PM	Rosen, Leading Trial Attorneys, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action - TEVA Newsfile
Nov-10-20 08:54PM	Teva Shareholder Alert Newsfile
03:10PM	ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm TEVA GlobeNewswire
09:16AM	6 Low Price-to-Book Value Stocks to Tap Market Boom Zacks
Nov-09-20 08:53PM	Teva Deadline Alert Newsfile +6.03%
Nov-08-20 10:34AM	Teva Class Action Reminder Newsfile
03:12AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline TEVA GlobeNewswire
Nov-07-20 12:18PM	ROSEN, A TOP RANKED FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA Newsfile
10:14AM	Teva Shareholder Notice Newsfile
Nov-06-20 10:53AM	TEVA Posts In-Line Q3 Earnings, Lowers Sales View, Stock Down Zacks +5.92%
Nov-05-20 11:02PM	Teva Pharmaceutical Industries (TEVA) Q3 2020 Earnings Call Transcript Motley Fool -6.51%
09:02PM	Teva Shareholder Alert Newsfile
04:17PM	Generic Pharma Behemoth Skids As Earnings Stall, Sales Lag Forecasts Investor's Business Daily
09:23AM	Teva 3rd-Quarter Adjusted Profit Meets Estimate; Revenue Lags TheStreet.com
08:40AM	TEVA Q3 Earnings In Line, Sales Miss, Stock Down Zacks
07:59AM	Teva's stock gains as it meets earnings expectations for the third quarter MarketWatch
07:00AM	Teva Reports Third Quarter 2020 Financial Results Business Wire
06:15AM	Teva Pharmaceutical Industries Ltd. to Host Earnings Call ACCESSWIRE
Nov-04-20 08:55PM	TEVA DEADLINE ALERT Newsfile
06:05PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline ACCESSWIRE
Nov-03-20 06:15PM	ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action TEVA GlobeNewswire
Nov-02-20 10:44PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline TEVA GlobeNewswire
08:33PM	Teva Deadline Alert Newsfile
11:10AM	Miller Value Partners is Betting on Teva Pharmaceutical Industries (TEVA) Stock Insider Monkey
08:45AM	TEVA Gears Up to Report Q3 Earnings: What's in the Cards? Zacks
Oct-31-20 11:27PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline - TEVA PR Newswire
10:33AM	TEVA CLASS ACTION REMINDER Newsfile
09:32AM	2 Stocks That Could Go Bankrupt in 2021 Motley Fool
Oct-30-20 08:40PM	ROSEN, A LEADING LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA PR Newswire
Oct-28-20 11:58PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline TEVA ACCESSWIRE
09:14PM	Teva Shareholder Notice Newsfile
05:08PM	Rosen, Top Ranked Investor Counsel, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA Newsfile
06:06AM	4 Top Value Stocks on Sale to Buy Right Now Motley Fool
Oct-27-20 09:13PM	Teva Shareholder Alert Newsfile
01:24PM	Israeli Cannabis Co. Univo Will Enter The U.K. Market Benzinga
Oct-26-20 09:09PM	Teva Deadline Alert Newsfile
08:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline TEVA GlobeNewswire
Oct-23-20 11:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline TEVA ACCESSWIRE
05:45PM	ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm TEVA GlobeNewswire

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Grady Brendan P.	EVP, North America Commercial	Mar 03	Sale	10.86	463	5,029	15,571	Mar 04 04:05 PM
Nazzi Gianfranco	EVP, International Markets	Mar 03	Sale	10.88	1,400	15,231	0	Mar 04 04:04 PM
Dethlefs Sven	EVP Global Marketing&Portfolio	Mar 03	Sale	10.86	606	6,583	70,058	Mar 04 04:02 PM
Daniell Richard	Exec. VP, European Commercial	Mar 03	Sale	10.88	993	10,803	11,873	Mar 04 04:01 PM
O'Grady Brendan P.	EVP, North America Commercial	Mar 02	Sale	10.85	15,085	163,601	14,868	Mar 04 04:05 PM
Fridriksdottir Hafrun	Executive VP, Global R&D	Mar 02	Sale	10.82	50,000	540,890	64,064	Mar 04 04:03 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Mar 01	Sale	10.83	18,430	199,612	2,974	Mar 02 04:10 PM
Nazzi Gianfranco	EVP, International Markets	Mar 01	Sale	10.87	75,587	821,925	0	Mar 02 04:07 PM
O'Grady Brendan P.	EVP, North America Commercial	Mar 01	Sale	10.91	73,127	798,023	29,953	Mar 02 04:07 PM
Fridriksdottir Hafrun	Executive VP, Global R&D	Mar 01	Sale	10.83	10,912	118,186	114,064	Mar 02 04:05 PM
Drape Eric	Executive VP Global Operations	Mar 01	Sale	10.85	9,795	106,285	49,291	Mar 02 04:04 PM
Dethlefs Sven	EVP Global Marketing&Portfolio	Mar 01	Sale	10.83	7,486	81,079	69,264	Mar 02 04:03 PM
Daniell Richard	Exec. VP, European Commercial	Mar 01	Sale	10.85	20,598	223,507	10,765	Mar 02 04:02 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Feb 16	Sale	11.12	3,926	43,669	2,974	Feb 17 04:09 PM
Fridriksdottir Hafrun	Executive VP, Global R&D	Feb 16	Sale	11.12	2,098	23,336	103,294	Feb 17 04:07 PM
Drape Eric	Executive VP Global Operations	Feb 16	Sale	11.13	2,079	23,135	39,572	Feb 17 04:06 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Feb 09	Sale	12.69	65,312	829,103	2,974	Feb 11 04:12 PM
O'Grady Brendan P.	EVP, North America Commercial	Feb 09	Sale	12.69	20,694	262,700	78,146	Feb 11 04:08 PM
Nazzi Gianfranco	EVP, International Markets	Feb 09	Sale	12.72	21,635	275,217	60,410	Feb 11 04:07 PM
Fridriksdottir Hafrun	Executive VP, Global R&D	Feb 09	Sale	12.69	29,496	374,437	100,037	Feb 11 04:05 PM
Drape Eric	Executive VP Global Operations	Feb 09	Sale	12.72	17,979	228,709	37,725	Feb 11 04:04 PM
Dethlefs Sven	EVP Global Marketing&Portfolio	Feb 09	Sale	12.69	29,657	376,481	59,404	Feb 11 04:03 PM
Daniell Richard	Exec. VP, European Commercial	Feb 09	Sale	12.72	68,422	870,389	10,765	Feb 11 04:02 PM
Daniell Richard	Exec. VP, European Commercial	Sep 09	Sale	8.98	333	2,992	10,765	Sep 10 09:04 AM
Crane Rosemary A	Director	Aug 11	Sale	11.90	2,860	34,038	33,509	Aug 13 04:07 PM
Griffin Deborah A	Chief Accounting Officer	Mar 17	Sale	7.16	944	6,762	0	Mar 19 08:09 AM
Stark David Matthew	Exec. VP Chief Legal Officer	Mar 17	Sale	7.16	2,359	16,899	2,974	Mar 19 07:38 AM
O'Grady Brendan P.	EVP, North America Commercial	Mar 17	Sale	7.16	470	3,367	14,868	Mar 19 07:37 AM
Nazzi Gianfranco	EVP, International Markets	Mar 17	Sale	7.17	345	2,474	19,844	Mar 19 07:36 AM
Fridriksdottir Hafrun	Executive VP, Global R&D	Mar 17	Sale	7.16	514	3,682	45,561	Mar 19 07:33 AM
Daniell Richard	Exec. VP, European Commercial	Mar 17	Sale	7.17	616	4,418	10,400	Mar 19 07:31 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience